Insider Cluster (2 insiders) ·Filed Mar 31, 2026

CYTK

CYTOKINETICS INC
BEARISH
Impact 6/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $736K total
Actionable Insight ▼ Bearish

Monitor for additional insider selling or downward revisions in guidance; CEO and top commercial executive selling simultaneously may signal caution ahead of key catalysts or clinical readouts.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CYTK ▲ +24.70% at T+60d
SHORT call ✗ call lost -24.70% · α vs SPY -12.32% · entry $65.91 → $82.19
Entry anchored
Mar 30, 03:59 PM ET
via exchange tick
T+1d
+1.06%
call -1.06% · α -0.31%
$66.61
settled 6mo ago
T+5d
-0.21%
call +0.21% · α +4.16%
$65.77
settled 6mo ago
T+20d
-10.38%
call +10.38% · α +19.80%
$59.07
settled 5mo ago
T+60d
+24.70%
call -24.70% · α -12.32%
$82.19
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two top executives at Cytokinetics, including CEO Robert Blum, sold shares in a coordinated 7-day window, generating $736,000 in total proceeds. The sales represent a modest but notable insider selling cluster, with both executives liquidating holdings at market prices.

Key Financial Metrics

Direction
selling
Total Value
$736.3K
Insiders
2

Key Facts

  • CEO Robert Blum sold 7,500 shares for $499,725 in open-market transaction on April 1, 2026.
  • EVP Andrew Callos sold 3,639 shares for $236,535 on March 31, 2026.
  • Total cluster value: $736,260 in open-market sales by C-suite executives.
  • Sales represent 0.009% of Cytokinetics' $8.1B market cap — modest in scale but concerning due to executive rank.

Financial Impact

$736K in insider sales over 7 days

insider ownershipinvestor sentiment

Risk Factors

  • Perception of insider lack of confidence, especially from CEO during critical development phase
  • Potential for negative market reaction if no offsetting positive news follows

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYTK-1775075710713
32 reports for CYTK
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+20▲ +10.38%Mar 31, 2026
Filters
Rows
Reports for CYTK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$69.31 $67.59▲ +2.48%▲ +4.59%$65.60 (+5.35%)
Sep 11, 2026
20d ago
Insider Cluster
NEUTRAL ★ 2/10
$72.45 $67.56▼ −6.75%▼ −6.86%$65.60 (−9.45%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 29, 2026
4w ago
Press Release
BULLISH ★ 7/10
$70.91 $75.35▲ +6.26%▲ +6.40%$65.60 (−7.49%)
Aug 28, 2026
5w ago
8-K
BULLISH ★ 7/10
$72.09 $72.72▲ +0.87%▲ +0.76%$65.60 (−9.00%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.42 $81.37▲ +1.18%▼ −2.44%$65.60 (−18.43%)
Jul 27, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.62 $77.13▼ −4.33%▼ −5.40%$65.60 (−18.63%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$80.74 $80.42▼ −0.40%▼ −0.77%$65.60 (−18.75%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.93 $79.11▼ −3.44%▼ −2.15%$65.60 (−19.93%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (65h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 1, 2026